{
    "organizations": [],
    "uuid": "889b9f009ebeb6ba242e641f6ea4451676b15022",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-adaptimmune-announces-positive-saf/brief-adaptimmune-announces-positive-safety-data-from-pilot-studies-with-mage-a10-spear-t-cells-idUSFWN1P30PO",
    "ord_in_thread": 0,
    "title": "BRIEF-Adaptimmune Announces Positive Safety Data From Pilot Studies With MAGE-A10 SPEAR T-Cells",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Adaptimmune Therapeutics Plc::\n* ADAPTIMMUNE ANNOUNCES POSITIVE SAFETY DATA FROM PILOT STUDIES WITH MAGE-A10 SPEAR T-CELLS AND FIRST PATIENT TO RECEIVE 1 BILLION TARGET CELL DOSE\n* ADAPTIMMUNE THERAPEUTICS PLC - NO EVIDENCE OF TOXICITY RELATED TO OFF-TARGET BINDING OR ALLOREACTIVITY HAS BEEN OBSERVED\n* ADAPTIMMUNE - IN NSCLC STUDY, THERE HAS BEEN ONE SERIOUS ADVERSE EVENT OF CYTOKINE RELEASE SYNDROME, A GRADE 4 EVENT THAT RESOLVED WITH TREATMENT\n* ADAPTIMMUNE THERAPEUTICS PLC - ADVERSE EVENT OF CYTOKINE RELEASE SYNDROME IN NSCLC STUDY LED TO COHORT 1 EXPANSION FROM 3 TO 6 PATIENTS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-08T21:13:00.000+02:00",
    "crawled": "2018-01-09T16:52:20.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "adaptimmune",
        "therapeutic",
        "plc",
        "adaptimmune",
        "announces",
        "positive",
        "safety",
        "data",
        "pilot",
        "study",
        "spear",
        "first",
        "patient",
        "receive",
        "billion",
        "target",
        "cell",
        "dose",
        "adaptimmune",
        "therapeutic",
        "plc",
        "evidence",
        "toxicity",
        "related",
        "binding",
        "alloreactivity",
        "observed",
        "adaptimmune",
        "nsclc",
        "study",
        "one",
        "serious",
        "adverse",
        "event",
        "cytokine",
        "release",
        "syndrome",
        "grade",
        "event",
        "resolved",
        "treatment",
        "adaptimmune",
        "therapeutic",
        "plc",
        "adverse",
        "event",
        "cytokine",
        "release",
        "syndrome",
        "nsclc",
        "study",
        "led",
        "cohort",
        "expansion",
        "patient",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}